Mankind Pharma, one of the best pharma companies in the country, became the 7th largest pharmaceutical company in India and retained its No.1 rank in a number of prescriptions.
Capital Structure refers to mixture of long term sources of the fund of the company. Researcher in the corporate finance has devoted extensive time and effort to determine the cause effect relationship of determinants of capital structure and its mix. But even after fifty five years of modiglian...
Anuh Pharma Limited is a Public Limited Company Listed on the National Stock Exchange and Bombay Stock Exchange. The Company is a part of the SK Group.
The Equity Shares offered through the DRHP are proposed to be listed on the BSE and the NSE. The company was incorporated in 1989, with the business to manufacture chlorinated paraffin and hydrochloric acid at its facility in Hyderabad. In 1990, it diversified its product portfolio to manufacture...
Company Codes:Bloomberg:SUNP, Bombay:524715, India:EQSUNPHARMA Mergers & acquisitionsAsia MORE ON THIS TOPIC Venture capitalists The Megaround Ruled Biopharma in 2024 as First-Time VC Funding Doubled January 9, 2025 · 2 min read ·
In the interim, the proceeds from this capital raise will also enable further strengthening of the Company’s balance sheet through deleveraging in the near term. *** About Piramal Enterprises Ltd: Piramal Enterprises Limited (PEL), a publicly listed company in India, has diversif...
is a private sector enterprise in India and operates in the Pharmaceuticals sector. The company has different verticals, which include Auro Trading Pvt. Ltd., APL Pharma Thai Ltd., Helix Health Care B.V Netherlands, Aurobindo Pharma USA Inc, Auro Pharma Inc., Canada, Aurobindo Pharma (Pty) ...
Sai Life Sciences specializes in contract research, development, and manufacturing organization (CRDMO) in the pharmaceutical and biotech sectors. The company offers services including drug discovery, development, and manufacturing of small molecules, focusing on the time to market for new medicines. Sai...
in India but also the industry leader on most operating parameters. Max Healthcare will always be a patient centric organization and will continue to put patients and their interests at the very core of what it does. I look forward to taking the company to newer heights with the excellent ...
Upon completion of the merger, currently expected to close in the first half of 2024, Taro will become a privately held company and its shares will no longer be listed on the NYSE. The Special Committee retainedBofA Securities, Inc.as its financial advisor,Goldfarb Gross Seligman& Co. as its...